Ann Partridge, MD, MPH Presents PROs from the COMET Study

Name: Ann Partridge, MD, MPH Presents PROs from the COMET Study
Uploaded: 2024-12-18T00:00:00+00:00
Description: Patients with low-risk DCIS who underwent active monitoring had comparable physical, emotional, and psychological outcomes to patients who received standard treatment, according to results from the phase 3 COMET trial data.

Patients with low-risk DCIS who underwent active monitoring had comparable physical, emotional, and psychological outcomes to patients who received standard treatment, according to results from the phase 3 COMET trial data presented by Dana-Farber's Ann Partridge, MD.

Related Presenters

Ann Partridge, MD

Medical Oncology

View full profile